Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Quanterix stock

QTRX
US74766Q1013
A2H9FB

Price

12.50
Today +/-
+0
Today %
+0 %
P

Quanterix stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Quanterix stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Quanterix stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Quanterix stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Quanterix's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Quanterix Stock Price History

DateQuanterix Price
10/2/202412.50 undefined
10/1/202412.50 undefined
9/30/202412.96 undefined
9/27/202412.73 undefined
9/26/202412.98 undefined
9/25/202413.15 undefined
9/24/202413.88 undefined
9/23/202413.89 undefined
9/20/202414.54 undefined
9/19/202415.49 undefined
9/18/202414.14 undefined
9/17/202413.20 undefined
9/16/202412.97 undefined
9/13/202412.82 undefined
9/12/202412.49 undefined
9/11/202412.07 undefined
9/10/202411.95 undefined
9/9/202411.99 undefined
9/6/202411.99 undefined
9/5/202412.25 undefined

Quanterix Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Quanterix, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Quanterix from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Quanterix’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Quanterix. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Quanterix’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Quanterix’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Quanterix’s growth potential.

Quanterix Revenue, EBIT and net profit per share

DateQuanterix RevenueQuanterix EBITQuanterix Net Income
2029e313.04 M undefined0 undefined0 undefined
2028e271.73 M undefined-19.07 M undefined-37.97 M undefined
2027e233.99 M undefined-34.68 M undefined-54.02 M undefined
2026e195.38 M undefined-34.98 M undefined-24.27 M undefined
2025e162.17 M undefined-46.02 M undefined-34.06 M undefined
2024e138.96 M undefined-51.51 M undefined-37.65 M undefined
2023122.37 M undefined-48.16 M undefined-32.33 M undefined
2022105.5 M undefined-72.4 M undefined-96.7 M undefined
2021110.6 M undefined-58.6 M undefined-57.7 M undefined
202086.4 M undefined-31.6 M undefined-31.5 M undefined
201956.7 M undefined-41.6 M undefined-40.8 M undefined
201837.6 M undefined-31.6 M undefined-31.5 M undefined
201722.9 M undefined-26 M undefined-31.2 M undefined
201617.6 M undefined-21.7 M undefined-27.6 M undefined
201512.2 M undefined-14.5 M undefined-20.3 M undefined

Quanterix Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
121722375686110105122138162195233271313
-41.6729.4168.1851.3553.5727.91-4.5516.1913.1117.3920.3719.4916.3115.50
41.6741.1845.4545.9546.4355.8155.4543.8157.38------
5710172648614670000000
-14-21-26-31-41-31-58-72-48-51-46-34-34-190
-116.67-123.53-118.18-83.78-73.21-36.05-52.73-68.57-39.34-36.96-28.40-17.44-14.59-7.01-
-20-27-31-31-40-31-57-96-32-37-34-24-54-370
-35.0014.81-29.03-22.5083.8768.42-66.6715.63-8.11-29.41125.00-31.48-
20.220.23.82225.129.6363737.59000000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The Quanterix Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Quanterix is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201520162017201820192020202120222023
                 
2.329.779.744.4109.2181.6396.5338.7321.32
2.33.95.66.810.917.223.81925.41
000000000
11.53.65.910.514.922.216.822.37
0.10.10.42.32.166.56.99.29
5.735.289.359.4132.7219.7449381.4378.39
1.11.21.92.91225.929.541.436.18
000000000
000000000
0002.314.313.710.57.56.03
0001.39.410.59.600
0.60.70.71.51.61.433.94.41
1.71.92.6837.351.552.652.846.62
7.437.191.967.4170271.2501.6434.2425.01
                 
73.4128.60000000.04
00210.2216.9345451.4745.9763.7783.14
-88.6-115.1-144.4-175.9-216.2-247.8-305.5-402.2-434.5
0000-0.22.40.4-2.6-1.76
000000000
-15.213.565.841128.6206440.8358.9346.93
1.32.53.65.15.86.89.23.85.05
2.94.16.27.69.116.921.218.123.94
1.53.44.95.44.98.56.699.47
000000000
2.10.9500.17.7000
7.810.919.718.119.939.93730.938.46
13.212.14.37.67.60000
000002.621.51.18
1.60.51.90.813.922.521.642.838.45
14.812.66.28.421.525.123.644.339.63
22.623.525.926.541.46560.675.278.08
7.43791.767.5170271501.4434.1425.01
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Quanterix provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Quanterix's financial health and stability.

Assets

Quanterix's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Quanterix must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Quanterix after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Quanterix's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
-15-23-27-31-40-31-57-96-32
000134456
000000000
011-34-7-122-11
34491321335635
000000000
000000000
-12-17-22-28-26-23-47-48-18
00-1-1-10-3-13-11-3
00-1-5-250-6-11-148
000-3-14370-144
000000000
400-100-700
7457411169627822
11457301169627022
---------
000000000
-12750-346472216-57-164
-13.12-18.27-23.24-30.24-37.04-27.3-61.53-60-22.69
000000000

Quanterix stock margins

The Quanterix margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quanterix. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quanterix.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Quanterix's sales revenue. A higher gross margin percentage indicates that the Quanterix retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Quanterix's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Quanterix's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Quanterix's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Quanterix. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Quanterix's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Quanterix Margin History

Quanterix Gross marginQuanterix Profit marginQuanterix EBIT marginQuanterix Profit margin
2029e57.73 %0 %0 %
2028e57.73 %-7.02 %-13.97 %
2027e57.73 %-14.82 %-23.09 %
2026e57.73 %-17.9 %-12.42 %
2025e57.73 %-28.38 %-21 %
2024e57.73 %-37.07 %-27.09 %
202357.73 %-39.36 %-26.42 %
202244.36 %-68.63 %-91.66 %
202155.79 %-52.98 %-52.17 %
202055.79 %-36.57 %-36.46 %
201947.27 %-73.37 %-71.96 %
201847.61 %-84.04 %-83.78 %
201743.67 %-113.54 %-136.24 %
201643.75 %-123.3 %-156.82 %
201546.72 %-118.85 %-166.39 %

Quanterix Stock Sales Revenue, EBIT, Earnings per Share

The Quanterix earnings per share therefore indicates how much revenue Quanterix has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quanterix earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quanterix's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quanterix’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quanterix's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Quanterix Revenue, EBIT and net profit per share

DateQuanterix Sales per ShareQuanterix EBIT per shareQuanterix Earnings per Share
2029e8.16 undefined0 undefined0 undefined
2028e7.08 undefined0 undefined-0.99 undefined
2027e6.1 undefined0 undefined-1.41 undefined
2026e5.09 undefined0 undefined-0.63 undefined
2025e4.23 undefined0 undefined-0.89 undefined
2024e3.62 undefined0 undefined-0.98 undefined
20233.25 undefined-1.28 undefined-0.86 undefined
20222.85 undefined-1.96 undefined-2.61 undefined
20213.07 undefined-1.63 undefined-1.6 undefined
20202.92 undefined-1.07 undefined-1.06 undefined
20192.26 undefined-1.66 undefined-1.63 undefined
20181.71 undefined-1.44 undefined-1.43 undefined
20176.03 undefined-6.84 undefined-8.21 undefined
20160.87 undefined-1.07 undefined-1.37 undefined
20150.6 undefined-0.72 undefined-1 undefined

Quanterix business model

Quanterix Corp is a company specialized in the development and distribution of innovative instruments and technologies for the precise measurement of biomarkers. The company was founded in 2007 by a renowned expert team in biotechnology and diagnostics and is headquartered in Lexington, Massachusetts, USA. The history of Quanterix Corp began with the vision of finding new ways to diagnose diseases earlier and more accurately. The founders recognized that conventional diagnostic methods are often inaccurate and time-consuming, and saw great potential in improving diagnostics through the targeted measurement of specific biomarkers. They wanted to establish a company specialized in the development of technologies for this type of diagnostics. Today, Quanterix Corp is a leading provider of ultrasensitive tests and technologies for biomarker measurement. The company has various divisions, including Life Sciences and Diagnostics. In the field of Life Sciences, Quanterix offers instruments and kits for biomarker research and development. They utilize the patented Simoa technology (Single Molecule Array), which enables ultrasensitive biomarker measurement in conjunction with digital detection systems. In the field of Diagnostics, Quanterix offers ultrasensitive tests for various clinical applications. Here, the company works closely with industry partners and academic institutions to utilize the technology in clinical research and diagnostics. The goal is to optimize therapy decisions, monitor treatment outcomes, and identify early indications of diseases. Quanterix products are in demand worldwide and are used in various fields. For example, tests for neurodegenerative diseases such as Alzheimer's, Parkinson's, or ALS are offered. These tests can help track disease progression and improve diagnosis. Quanterix's ultrasensitive tests also play a role in oncology, where they can help detect cancer early or measure treatment success. Quanterix's business model is based on collaboration with partners from the pharmaceutical industry, academic institutions, and clinics. Quanterix sees itself as an enabler for the development of new therapies and diagnostic methods. Through collaboration with various partners, new innovations in research and diagnostics are made possible. In summary, Quanterix Corp is a leading company in the development and marketing of ultrasensitive tests and technologies for biomarker measurement. The company has various divisions and offers products for Life Sciences as well as Diagnostics. The Simoa technology allows for higher precision and accuracy in biomarker measurement. Quanterix's goal is to promote medical progress and provide patients with better diagnostic and therapeutic care through its technologies and tests. Quanterix is one of the most popular companies on Eulerpool.com.

Quanterix SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Quanterix Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Quanterix historical P/E ratio, EBIT multiple, and P/S ratio

Quanterix shares outstanding

The number of shares was Quanterix in 2023 — This indicates how many shares 37.594 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quanterix earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quanterix's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quanterix’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quanterix's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Quanterix.

Quanterix latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.27 -0.25  (8.09 %)2024 Q2
3/31/2024-0.32 -0.26  (19.08 %)2024 Q1
12/31/2023-0.32 -0.33  (-1.73 %)2023 Q4
9/30/2023-0.38 -0.21  (44.36 %)2023 Q3
6/30/2023-0.39 -0.16  (58.45 %)2023 Q2
3/31/2023-0.39 -0.16  (59 %)2023 Q1
12/31/2022-0.48 -0.5  (-4.84 %)2022 Q4
9/30/2022-0.43 -0.95  (-121.76 %)2022 Q3
6/30/2022-0.49 -0.67  (-35.44 %)2022 Q2
3/31/2022-0.62 -0.49  (20.99 %)2022 Q1
1
2
3

Eulerpool ESG Scorecard© for the Quanterix stock

Eulerpool World ESG Rating (EESG©)

36/ 100

🌱 Environment

39

👫 Social

43

🏛️ Governance

26

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees44
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Quanterix shareholders

%
Name
Stocks
Change
Date
7.20207 % BlackRock Institutional Trust Company, N.A.2,764,155256,18212/31/2023
5.75708 % Millennium Management LLC2,209,566229,65512/31/2023
5.33372 % The Vanguard Group, Inc.2,047,08057,73812/31/2023
3.73700 % Walt (David R)1,434,2592,9471/2/2024
3.72662 % Lord, Abbett & Co. LLC1,430,277408,02412/31/2023
3.37960 % Portolan Capital Management, L.L.C.1,297,090-378,74812/31/2023
3.13290 % Gilder Gagnon Howe & Co. LLC1,202,408-23,79712/31/2023
2.73113 % Emerald Advisers LLC1,048,207349,66712/31/2023
2.53807 % Dimensional Fund Advisors, L.P.974,111131,19512/31/2023
2.16750 % Ashford Capital Management, Inc.831,88533,86012/31/2023
1
2
3
4
5
...
10

Quanterix Executives and Management Board

Dr. Masoud Toloue42
Quanterix President, Chief Executive Officer, Director (since 2021)
Compensation 2.96 M
Ms. Karen Flynn60
Quanterix Independent Director
Compensation 425,735
Dr. Martin Madaus63
Quanterix Independent Chairman of the Board (since 2010)
Compensation 275,978
Mr. Paul Meister70
Quanterix Independent Director
Compensation 259,976
Ms. Sarah Hlavinka58
Quanterix Independent Director
Compensation 256,940
1
2

Quanterix Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Bio-Techne Stock
Bio-Techne
SupplierCustomer0,810,880,890,850,75-
STRATEC Stock
STRATEC
SupplierCustomer0,510,800,790,820,63-
Siemens Healthineers Stock
Siemens Healthineers
SupplierCustomer0,18-0,400,550,850,11-
WuXi AppTec Co H Stock
WuXi AppTec Co H
SupplierCustomer0,150,920,640,740,86-
Abbott Laboratories Stock
Abbott Laboratories
SupplierCustomer0,120,510,790,910,15-
Eli Lilly Stock
Eli Lilly
SupplierCustomer0,05-0,08-0,28-0,47-0,64-
1

Most common questions regarding Quanterix

What values and corporate philosophy does Quanterix represent?

Quanterix Corp represents values of innovation, precision, and dedication to advancing science and healthcare. With a strong corporate philosophy focused on transforming medicine through their proprietary technology, they strive to revolutionize diagnostics and biomarker analysis. Quanterix Corp is committed to developing highly sensitive biomarker detection solutions that enable researchers and clinicians to detect diseases far earlier and more accurately than previously possible. Continuously pushing the boundaries of scientific knowledge, Quanterix Corp's pioneering approach has the potential to improve patient outcomes and revolutionize the way healthcare industry operates.

In which countries and regions is Quanterix primarily present?

Quanterix Corp is primarily present in the United States and Europe.

What significant milestones has the company Quanterix achieved?

Quanterix Corp has achieved several significant milestones since its inception. The company's groundbreaking Simoa technology has revolutionized the field of ultra-sensitive biomarker analysis, enabling researchers to detect and measure extremely low levels of proteins and biomarkers. Quanterix Corp has also developed a strong portfolio of diagnostic tests for various diseases and conditions, such as neurodegenerative diseases, oncology, and infectious diseases. Moreover, the company has received numerous accolades and recognitions for its innovative approach, including being named a Technology Pioneer by the World Economic Forum. Quanterix Corp continues to advance in its mission to improve healthcare outcomes through cutting-edge diagnostics and precision medicine.

What is the history and background of the company Quanterix?

Quanterix Corp is a renowned biotechnology company founded in 2007. With its headquarters in Billerica, Massachusetts, the company specializes in developing ultra-sensitive analysis platforms, known as Simoa, for studying and measuring various biomarkers in life sciences. Quanterix Corp has revolutionized the field of biomarker analysis by enabling detection at previously unattainable levels, enabling breakthroughs in diagnostics, precision medicine, and life sciences research. The company's unparalleled technology has attracted collaborations with prominent academic institutions, pharmaceutical companies, and clinical laboratories worldwide. Quanterix Corp's commitment to innovation and improving patient outcomes has positioned it as a leading player in the field of precision health.

Who are the main competitors of Quanterix in the market?

The main competitors of Quanterix Corp in the market are companies like Bio-Techne Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, and Merck KGaA.

In which industries is Quanterix primarily active?

Quanterix Corp is primarily active in the life sciences and diagnostics industries.

What is the business model of Quanterix?

The business model of Quanterix Corp focuses on developing and commercializing ultra-sensitive biomarker detection systems. By leveraging their proprietary Simoa technology, the company aims to provide researchers and clinicians with the tools necessary to advance precision medicine and improve the detection and treatment of various diseases. Quanterix Corp's cutting-edge platforms enable the measurement of previously undetectable biomarkers, opening up new possibilities in diagnostics, drug development, and personalized healthcare. With their dedication to innovation and pushing the boundaries of detection, Quanterix Corp strives to make a significant impact in the field of life sciences and transform the way diseases are diagnosed and monitored.

What is the P/E ratio of Quanterix 2024?

The Quanterix P/E ratio is -12.48.

What is the P/S ratio of Quanterix 2024?

The Quanterix P/S ratio is 3.38.

What is the AlleAktien quality score of Quanterix?

The AlleAktien quality score for Quanterix is 4/10.

What is the revenue of Quanterix 2024?

The expected Quanterix revenue is 138.96 M USD.

How high is the profit of Quanterix 2024?

The expected Quanterix profit is -37.65 M USD.

What is the business model of Quanterix

Quanterix Corp is a company that specializes in the development and sale of instruments and reagents for digital diagnostic applications. It is working on developing technologies that increase the accuracy and sensitivity of tests, enabling better disease diagnosis and monitoring. The company's business model is based on three main divisions: instruments, reagents, and services. They offer automated systems that can conduct biomarker analysis at the single-molecule level. The company also provides training and consulting services for the use of their instruments and reagents. They are known for their Simoa technology, which is used for disease diagnosis based on the measurement of biomarkers in blood. Quanterix Corp works closely with leading companies in the life science industry to integrate their technology into their products. Overall, the company is recognized as a key player in the field of digital diagnostics.

What is the Quanterix dividend?

Quanterix pays a dividend of 0 USD distributed over payouts per year.

How often does Quanterix pay dividends?

The dividend cannot currently be calculated for Quanterix or the company does not pay out a dividend.

What is the Quanterix ISIN?

The ISIN of Quanterix is US74766Q1013.

What is the Quanterix WKN?

The WKN of Quanterix is A2H9FB.

What is the Quanterix ticker?

The ticker of Quanterix is QTRX.

How much dividend does Quanterix pay?

Over the past 12 months, Quanterix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quanterix is expected to pay a dividend of 0 USD.

What is the dividend yield of Quanterix?

The current dividend yield of Quanterix is .

When does Quanterix pay dividends?

Quanterix pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Quanterix?

Quanterix paid dividends every year for the past 0 years.

What is the dividend of Quanterix?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Quanterix located?

Quanterix is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quanterix kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quanterix from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Quanterix pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Quanterix in the year 2023?

In the year 2023, Quanterix distributed 0 USD as dividends.

In which currency does Quanterix pay out the dividend?

The dividends of Quanterix are distributed in USD.

All fundamentals about Quanterix

Our stock analysis for Quanterix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quanterix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.